abstract |
The present invention provides biomarkers for pre-diabetes, diabetes, and / or diabetes-related symptoms, and methods for their use. A method for discriminating a subject for diabetes comprising measuring at least one biomarker in a sample from the subject, wherein the at least one biomarker is CD5 antigen-like. And how to. The at least one biomarker further comprises peroxiredoxin-2, complement C1q subunit B, apolipoprotein C-III, insulin-like growth factor binding protein 3, adiponectin, complement factor H-related protein 2, hemoglobin sub A method comprising a biomarker selected from a list of biomarkers comprising unit beta, apolipoprotein B-100, sulfhydryl oxidase 1, complement component C8 beta chain and apolipoprotein A-IV. [Selection] Figure 1 |